Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=12

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT04652102-84eb655c",
        "title": "CVnCoV 12 μg Vaccine vs Placebo: Number of Participants Who Experienced a Fatal SAE",
        "summary": "11 of 19787 against 12 of 19753; risk difference -0.0 points, 95% interval -0.1 to 0.0; NCT04652102, A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older",
        "record": "/library/comparisons/NCT04652102-84eb655c",
        "nct_id": "NCT04652102",
        "kind": "outcome",
        "participants": 39540,
        "risk_difference": {
          "value": -0.00005158210392510333,
          "lower": -0.0005678153532326032,
          "upper": 0.00045890707959811157
        },
        "group_1": "11 of 19,787",
        "group_2": "12 of 19,753",
        "difference": "-0.0 points",
        "interval": "-0.1 to 0.0",
        "trial_title": "A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older"
      },
      {
        "id": "NCT04652102-deaths",
        "title": "CVnCoV 12 μg Vaccine vs Placebo: deaths from any cause",
        "summary": "17 of 19787 against 14 of 19753; risk difference 0.0 points, 95% interval -0.0 to 0.1; NCT04652102, A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older",
        "record": "/library/comparisons/NCT04652102-deaths",
        "nct_id": "NCT04652102",
        "kind": "deaths",
        "participants": 39540,
        "risk_difference": {
          "value": 0.0001503968461400402,
          "lower": -0.0004285134493507009,
          "upper": 0.0007409631357310506
        },
        "group_1": "17 of 19,787",
        "group_2": "14 of 19,753",
        "difference": "0.0 points",
        "interval": "-0.0 to 0.1",
        "trial_title": "A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=13",
  "request_id": "N7o2neoX3j_1wIdA"
}